Jounce Therapeutics, Inc. announced the appointment of Barbara G. Duncan to the company's board of directors. Ms. Duncan brings to the company almost 30 years of financial leadership experience, with over 15 of those years in management roles within the pharmaceutical industry. Ms. Duncan has spent the last seven years as chief financial officer and treasurer at Intercept Pharmaceuticals, Inc. Previously, Ms. Duncan held various senior leadership roles of increasing responsibility at DOV Pharmaceutical, Inc., including as chief executive officer.